Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease

Status Terminated

Clinical Trial Summary

The exploration of neoplastic pulmonary pathology is based on computed tomography and bronchoscopy. This allows targeted samples of the identified lesions.

A new ultrasonographic method is proposed as a non invasive and non irradiating technic by using a dedicated probe easily introduced via the channel of the fibrescope, so as to complete the identification of peripheral lesions.

Clinical Trial Description

The main objective of the study is to assess the ability of endobronchial ultrasonography to diagnose peripheral pulmonary lesions during the bronchoscopy and to correlate the abnormalities to computed tomography and/or histology.

The dedicated probe consist of a linear array of 2-3 mm in diameter connected to a commercial unit. ;

Study Design

Observational Model: Defined Population, Time Perspective: Longitudinal

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00241267
Study type	Observational
Source	University Hospital, Tours
Contact
Status	Terminated
Phase	N/A
Start date	March 2005
Completion date	March 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01860898` - A Phase I Study of iPS Cell Generation From Patients With COPD	N/A
Completed	`NCT05011890` - Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®	N/A
Completed	`NCT00290953` - Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide	Phase 2/Phase 3
Completed	`NCT00132639` - Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)	Phase 2
Terminated	`NCT02673021` - MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)	N/A
Terminated	`NCT00232128` - Protocol for Radiofrequency Ablation of Pulmonary Neoplasms	N/A
Completed	`NCT00042679` - A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.	Phase 2
Not yet recruiting	`NCT05857995` - Precision Lung Cancer Survivorship Care Intervention	N/A
Recruiting	`NCT04699188` - Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation	Phase 1/Phase 2
Completed	`NCT02410603` - Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
Recruiting	`NCT02549638` - Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
Completed	`NCT02483052` - RejuvenAir Lobectomy for Safety and Histology	Phase 1/Phase 2
Completed	`NCT02370303` - A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
Completed	`NCT01470248` - Study of Arsenic Trioxide in Small Cell Lung Cancer	Phase 2
Completed	`NCT00922155` - Diagnosis of Lung Lesions by Endobronchial Ultrasound With an Alternative Guide Sheath	N/A